TGF-beta-1/Smad3 signaling inhibitors (Nankai University)

N/A

Report date: 2025/03/19 18:26:21
NME

Base Information

Drug NameTGF-beta-1/Smad3 signaling inhibitors (Nankai University)
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionMothers against decapentaplegic homolog 3 inhibitorsTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1Mothers against decapentaplegic homolog 3
Therapy Area/IndicationsPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNankai University
China Registration ClassN/A

Develop Information

Active CompaniesNankai University
Inactive CompaniesN/A
Active IndicationsPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A